Nj. Froggatt et al., LOW-FREQUENCY AND LATE OCCURRENCE OF P53 AND DCC ABERRATIONS IN COLORECTAL TUMORS, Journal of cancer research and clinical oncology, 121(1), 1995, pp. 7-15
Whilst p53 aberrations have been documented in numerous malignancies,
reports of alterations to the deleted in colorectal cancer (dcc) gene
are infrequent, and studies investigating the status of both genes in
the same colon tumour are rare. In this study we have analysed a panel
of 35 pairs of normal and neoplastic human colorectal tissues for abn
ormalities in these tumour-suppressor genes. In contrast to previous s
tudies we have found only a low incidence of mutations and deletions.
p53 point mutations were identified in 8/35 tumours (22%). All were G.
C to A.T transitions, with 7/8 occurring at CpG dinucleotides. p53 all
elic loss was detected in 4/11 informative cases (36%). Although not q
uite attaining statistical significance, p53 alteration correlated wit
h the adenoma/carcinoma transition. Gross dcc alterations were identif
ied by Southern blotting in 7/35 (20%) tumours. Microsatellite analysi
s using two markers, one within and one proximal to the dcc gene, dete
cted a low frequency of deletion overall (41% informative cases). 18q/
dcc aberrations were associated with the progression of early to late
carcinoma, rather than with increasing adenoma size, as has been previ
ously reported. Both p53 alterations and dcc deletions were detected a
t a higher frequency in distal tumours than in proximal malignancies.
Two tumours exhibiting microsatellite instability in both markers were
each of proximal origin.